BIOMAT Database Logo BIOMAT Database Logo

[Colorectal carcinoma: significance of the tumor marker]. 1988

W H Schmiegel
Medizinische Klinik, Universitätskrankenhaus Hamburg-Eppendorf.

The comparison between carcinoembryonic antigen (CEA) and novel mucin or mucin-like tumour markers in colorectal cancer still favours CEA with regard to sensitivity and specificity. While not contributing to screening and primary diagnostic procedures, its value as a prognostic marker including preoperative staging and post-surgical follow-up, has been well established.

UI MeSH Term Description Entries
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers

Related Publications

W H Schmiegel
Significance of tenascin serum level as tumor marker in primary colorectal carcinoma.
February 1995, International journal of cancer,
W H Schmiegel
Significance of tumor marker SLX in colorectal cancer.
January 1997, Oncology reports,
W H Schmiegel
Neopterin. A tumor marker in colorectal carcinoma?
November 1987, Diseases of the colon and rectum,
W H Schmiegel
[Tumor marker and its clinical significance in diagnosis of colorectal cancer].
September 2003, Nihon rinsho. Japanese journal of clinical medicine,
W H Schmiegel
Clinical significance of immunosuppressive substance as a marker for colorectal carcinoma.
August 1987, Journal of clinical gastroenterology,
W H Schmiegel
[Significance of a new tumor marker for breast carcinoma and ovarian carcinoma].
May 1987, Deutsche medizinische Wochenschrift (1946),
W H Schmiegel
[Prognostic significance of tumor-induced angiogenesis in colorectal carcinoma].
January 2003, Medicinski pregled,
W H Schmiegel
Clinical significance of tumor suppressor PTEN in colorectal carcinoma.
February 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
W H Schmiegel
Significance of Serum p53 Antibody as a Tumor Marker in Colorectal Cancer.
January 2019, Disease markers,
W H Schmiegel
[Clinical significance of the tumor marker CA 15-3 in mammary carcinoma].
November 1986, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!